Efficacy of Bortezomib as an Adjunctive Therapy for Refractory Chronic Active Antibody-Mediated Rejection in Kidney Transplant Patients: A Single-Center Experience
© 2019 Elsevier Inc. Background: Chronic active antibody-mediated rejection (CAMR) has unsatisfactory prognosis in spite of intensive standard antihumoral treatment. Efficacy of additional bortezomib in CAMR remains uncertain. Methods: A retrospective chart review was conducted among kidney transpla...
Saved in:
Main Authors: | Nuttasith Larpparisuth, Peenida Skulratanasak, Nalinee Premasathian, Attapong Vongwiwatana |
---|---|
Other Authors: | Faculty of Medicine, Siriraj Hospital, Mahidol University |
Format: | Article |
Published: |
2020
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/51254 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Effect on Dosage Change and Intrapatient Variability After Conversion From Twice-Daily to Once-Daily Tacrolimus Among Thai Kidney Transplant Patients With and Without CYP3A4/5 Inhibitors
by: Nuttasith Larpparisuth, et al.
Published: (2020) -
Preemptive Living-Related Kidney Transplantation Is a Cost-Saving Strategy Compared With Post-dialysis Kidney Transplantation in Thailand
by: Atthaphong Phongphithakchai, et al.
Published: (2022) -
High Intrapatient Variability in Tacrolimus Exposure Calculated Over a Long Period Is Associated With De Novo Donor-Specific Antibody Development and/or Late Rejection in Thai Kidney Transplant Patients Receiving Concomitant CYP3A4/5 Inhibitors
by: Nuttasith Larpparisuth, et al.
Published: (2022) -
A Study of the Pharmacokinetic Comparison between the Generic and Original Form of Mycophenolate Mofetil Among Thai Renal Transplant Patients
by: Nuttasith Larpparisuth, et al.
Published: (2020) -
Clinicopathologic characteristics and outcomes of late acute antibody-mediated rejection in Thai Kidney Transplant recipients: A single-center experience
by: N. Larpparisuth, et al.
Published: (2018)